The Effect of Working at Home to Reduce Risk of Respiratory Infection

NCT05298488 | Unknown

• 1 other identifier: CristinID2535463
• Study Type: interventional
• Target: 2,000
• Locations: 1 country
• Sites: 1

Brief Summary

The researchers will recruit volunteers from various organisations who are willing and able to be randomised to either working from home for 4 weeks followed by working in the office for 4 weeks, or vice versa. The goal is to assess whether working from home has an impact on the risk of symptoms of respiratory infection.

Conditions

Respiratory Tract Infections; COVID-19

Keywords

COVID-19; Infection control; Office from home; Social distancing

Outcome Measures

Primary Outcomes (1)

• Respiratory infection

  The proportion of participants who report having had symptoms of respiratory disease

  8 weeks

Secondary Outcomes (5)

• COVID-19

  8 weeks

• Absenteeism

  8 weeks

• Secondary cases of respiratory infection

  8 weeks

• Work-satisfaction

  8 weeks

• Work-life balance.

  8 weeks

Study Arms (2)

Home office for first 4 weeks, and office for the last 4 weeks

EXPERIMENTAL

Participants will work from home for first 4 weeks, and at the office for the last 4 weeks

Behavioral: Home office; Behavioral: Office

Office for first 4 weeks, and home office for the last 4 weeks

ACTIVE COMPARATOR

Participants will work at the office for the first 4 weeks, and from home during the last 4 weeks

Behavioral: Home office; Behavioral: Office

Interventions

Home office BEHAVIORAL

Working from home

Home office for first 4 weeks, and office for the last 4 weeks; Office for first 4 weeks, and home office for the last 4 weeks

Office BEHAVIORAL

Working at the office

Home office for first 4 weeks, and office for the last 4 weeks; Office for first 4 weeks, and home office for the last 4 weeks

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Over 18 years old
• Employee in a company/organisation that has agreed to let their employees take part
• Willing and able to work form home for 4 weeks (most of the time)
• \- Unable to work from home

Sponsors & Collaborators

• Norwegian Institute of Public Health: lead
• The National Institute of Occupational Health, Norway: collaborator

Study Sites (1)

Norwegian Institute of Public Health

Oslo, 0213, Norway

RECRUITING

MeSH Terms

Conditions

Respiratory Tract Infections; COVID-19

Interventions

Working Conditions

Condition Hierarchy (Ancestors)

Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases

Intervention Hierarchy (Ancestors)

Workplace; Employment; Socioeconomic Factors; Population Characteristics; Personnel Management; Organization and Administration; Health Services Administration

Study Officials

• Atle Fretheim, PhD

  Head of Centre for Epidemic Interventions Research (CEIR)

  STUDY DIRECTOR

Central Study Contacts

Petter Elstrom, PhD

CONTACT

+47 91149202; petter.elstrom@fhi.no

Atle Fretheim, PhD

CONTACT

atle.fretheim@fhi.no

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR

Model Details: The participants will be allocated to either office from home for the first four weeks, followed by working at the office for four weeks, or vice versa.

Study Record Dates

• First Submitted: March 7, 2022
• First Posted: March 28, 2022
• Study Start: March 14, 2022
• Primary Completion: March 30, 2023
• Study Completion: September 30, 2023
• Last Updated: March 28, 2022

Record last verified: 2022-03

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF
• Time Frame: After reporting of the trial findings, estimated to June 2023.

Locations

NO (1)